Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:22 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)FutureClinic
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Sep 2024). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Sep 2024). Investors: Y Combinator. (High).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
YC Fall 2024; platform for doctors to run digital clinics with 99% AI / 1% physician review model.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:22 PM · confidence 88%high quality
Wed, May 20, 06:22 PM · confidence 85%medium quality
Newest first · 5 event(s)
Source: Blog
Writing from FutureClinic clinicians and team on modern primary care, the craft of medicine, and what we’re building.
Source: Homepage
Get healthcare from real, licensed doctors through chat. Start a conversation with our AI assistant, choose your doctor, and get care, all online.
Be a personal doctor through chat; cash-pay subscription care.
YC Fall 2024; platform for doctors to run digital clinics with 99% AI / 1% physician review model.
Scalable async care with physician oversight.
2 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Get healthcare from real, licensed doctors through chat. Start a conversation with our AI assistant, choose your doctor, and get care, all online.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Be a personal doctor through chat; cash-pay subscription care.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗1 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Scalable async care with physician oversight.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
YC Fall 2024; platform for doctors to run digital clinics with 99% AI / 1% physician review model.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗1 row(s)
Company blog and newsletters. Shipping cadence and technical depth of posts hint at product velocity and team quality.
Writing from FutureClinic clinicians and team on modern primary care, the craft of medicine, and what we’re building.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.